- Home
- KURA vs IGR Comparison
KURA vs IGR Comparison
Compare KURA & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | IGR |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.0M | 645.2M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | IGR |
|---|---|---|
| Price | $8.95 | $4.79 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $26.88 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 754.3K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $124.03 | N/A |
| Revenue Next Year | $28.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.41 | $4.20 |
| 52 Week High | $12.49 | $5.37 |
Technical Indicators
Market Signals| Indicator | KURA | IGR |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 44.17 |
| Support Level | $8.09 | $4.65 |
| Resistance Level | $10.50 | $4.86 |
| Average True Range (ATR) | 0.39 | 0.08 |
| MACD | 0.09 | -0.03 |
| Stochastic Oscillator | 96.49 | 16.45 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.